Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci U S A. 2000;97(4):1444–9.
Article CAS PubMed PubMed Central Google Scholar
Arnold PK, Finley LWS. Regulation and function of the mammalian tricarboxylic acid cycle. J Biol Chem. 2023;299(2):102838.
Article CAS PubMed Google Scholar
Arruda AC, Perilhão MS, Santos WA, Gregnani MF, Budu A, Neto JCR, Estrela GR, Araujo RC. PPARα-dependent modulation by metformin of the expression of OCT-2 and MATE-1 in the kidney of mice. Molecules. 2020;25(2):392.
Article CAS PubMed PubMed Central Google Scholar
Arzumanian VA, Kiseleva OI, Poverennaya EV. The curious case of the HepG2 cell line: 40 years of expertise. Int J Mol Sci. 2021;22(23):13135.
Article CAS PubMed PubMed Central Google Scholar
Baeken MW, Koetzner P, Richly H, Behl C, Moosmann B, Hajieva P. Adaptive epigenetic regulation of neuronal metabolism by a mitochondrial redox signal. BioRxiv. 2023;570533. https://doi.org/10.1101/2023.12.10.570533v1
Bartlett K, Eaton S. Mitochondrial beta-oxidation. Eur J Biochem. 2004;271(3):462–9.
Article CAS PubMed Google Scholar
Baur JA, Birnbaum MJ. Control of gluconeogenesis by metformin: does redox trump energy charge? Cell Metab. 2014;20(2):197–9.
Article CAS PubMed PubMed Central Google Scholar
Beal MF. Experimental models of Parkinson’s disease. Nat Rev Neurosci. 2001;2(5):325–34.
Article CAS PubMed Google Scholar
Beck-Nielsen H, Hother-Nielsen O, Staehr P. Is hepatic glucose production increased in type 2 diabetes mellitus? Curr Diab Rep. 2002;2(3):231–6.
Bender A, Hajieva P, Moosmann B. Adaptive antioxidant methionine accumulation in respiratory chain complexes explains the use of a deviant genetic code in mitochondria. Proc Natl Acad Sci U S A. 2008;105(43):16496–501.
Article CAS PubMed PubMed Central Google Scholar
Benton CR, Holloway GP, Campbell SE, Yoshida Y, Tandon NN, Glatz JF, Luiken JJ, Spriet LL, Bonen A. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J Physiol. 2008;586(6):1755–66.
Article CAS PubMed PubMed Central Google Scholar
Boden G, Homko C, Mozzoli M, Showe LC, Nichols C, Cheung P. Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes. 2005;54(3):880–5.
Article CAS PubMed Google Scholar
Borner T, Shaulson ED, Ghidewon MY, Barnett AB, Horn CC, Doyle RP, Grill HJ, Hayes MR, De Jonghe BC. GDF15 induces anorexia through nausea and emesis. Cell Metab. 2020;31(2):351-362.e5.
Article CAS PubMed PubMed Central Google Scholar
Bourron O, Daval M, Hainault I, Hajduch E, Servant JM, Gautier JF, Ferré P, Foufelle F. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia. 2010;53(4):768–78.
Article CAS PubMed Google Scholar
Breit SN, Brown DA, Tsai VW. The GDF15-GFRAL pathway in health and metabolic disease: friend or foe? Annu Rev Physiol. 2021;10(83):127–51.
Bridges HR, Jones AJ, Pollak MN, Hirst J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J. 2014;462(3):475–87.
Article CAS PubMed Google Scholar
Bridges HR, Blaza JN, Yin Z, Chung I, Pollak MN, Hirst J. Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides. Science. 2023;379(6630):351–7.
Article CAS PubMed PubMed Central Google Scholar
Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Nohl H, Waldhäusl W, Fürnsinn C. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes. 2004;53(4):1052–9.
Article CAS PubMed Google Scholar
Brunmair B, Lest A, Staniek K, Gras F, Scharf N, Roden M, Nohl H, Waldhäusl W, Fürnsinn C. Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. J Pharmacol Exp Ther. 2004;311(1):109–14.
Article CAS PubMed Google Scholar
Budde K, Neumayer HH, Fritsche L, Sulowicz W, Stompôr T, Eckland D. The pharmacokinetics of pioglitazone in patients with impaired renal function. Br J Clin Pharmacol. 2003;55(4):368–74.
Article CAS PubMed PubMed Central Google Scholar
Cameron AR, Logie L, Patel K, Erhardt S, Bacon S, Middleton P, Harthill J, Forteath C, Coats JT, Kerr C, Curry H, Stewart D, Sakamoto K, Repiščák P, Paterson MJ, Hassinen I, McDougall G, Rena G. Metformin selectively targets redox control of complex I energy transduction. Redox Biol. 2018;14:187–97.
Article CAS PubMed Google Scholar
Caro P, Gómez J, López-Torres M, Sánchez I, Naudí A, Jove M, Pamplona R, Barja G. Forty percent and eighty percent methionine restriction decrease mitochondrial ROS generation and oxidative stress in rat liver. Biogerontology. 2008;9(3):183–96.
Article CAS PubMed Google Scholar
Castano-Martinez T, Schumacher F, Schumacher S, Kochlik B, Weber D, Grune T, Biemann R, McCann A, Abraham K, Weikert C, Kleuser B, Schürmann A, Laeger T. Methionine restriction prevents onset of type 2 diabetes in NZO mice. FASEB J. 2019;33(6):7092–102.
Article CAS PubMed PubMed Central Google Scholar
Chang JS. Recent insights into the molecular mechanisms of simultaneous fatty acid oxidation and synthesis in brown adipocytes. Front Endocrinol (Lausanne). 2023;21(14):1106544.
Clarke SD. Regulation of fatty acid synthase gene expression: an approach for reducing fat accumulation. J Anim Sci. 1993;71(7):1957–65.
Article CAS PubMed Google Scholar
Damci T, Tatliagac S, Osar Z, Ilkova H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. Eur J Intern Med. 2003;14(6):357–60.
Article CAS PubMed Google Scholar
Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: an overview. Biochim Biophys Acta. 1998;1364(2):222–35.
Article CAS PubMed Google Scholar
de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes. 2001;50(8):1863–71.
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.
Article CAS PubMed Google Scholar
Even PC, Rolland V, Roseau S, Bouthegourd JC, Tomé D. Prediction of basal metabolism from organ size in the rat: relationship to strain, feeding, age, and obesity. Am J Physiol Regul Integr Comp Physiol. 2001;280(6):R1887–96.
Article CAS PubMed Google Scholar
Fang H, Stone KP, Forney LA, Wanders D, Gettys TW. Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine. Front Endocrinol (Lausanne). 2021;12.
Article PubMed PubMed Central Google Scholar
Ferreira JP, Vasques-Nóvoa F, Ferrão D, Saraiva F, Falcão-Pires I, Neves JS, Sharma A, Rossignol P, Zannad F, Leite-Moreira A. Fenofibrate and heart failure outcomes in patients with type 2 diabetes: analysis from ACCORD. Diabetes Care. 2022;45(7):1584–91.
Article CAS PubMed PubMed Central Google Scholar
Foretz M, Hébrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, Sakamoto K, Andreelli F, Viollet B. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010;120(7):2355–69.
Article CAS PubMed PubMed Central Google Scholar
Forney LA, Fang H, Sims LC, Stone KP, Vincik LY, Vick AM, Gibson AN, Burk DH, Gettys TW. Dietary methionine restriction signals to the brain through fibroblast growth factor 21 to regulate energy balance and remodeling of adipose tissue. Obesity (Silver Spring). 2020;28(10):1912–21.
Article CAS PubMed Google Scholar
Fürnsinn C, Waldhäusl W. Thiazolidinediones: metabolic actions in vitro. Diabetologia. 2002;45(9):1211–23.
留言 (0)